MedCity News

MedCity Influencers

Healthcare Staff can Maximize the Value of AI with High Performing Endpoints

By Kevin Greenway

MedCity Influencers

Concussion Protocols: What Providers Should Know to Diagnose, Treat, and Rehabilitate

Here are five things providers should know about concussions.

By Dr. Al Cobb

How Mass General Brigham Decides Which AI Tools Are Worth Scaling

Mass General Brigham evaluates AI tools by carefully monitoring real-world performance before scaling them system-wide. At HIMSS earlier this month, Rebecca Mishuris, the health system’s chief health information officer and vice president of digital, explained what this process looks like.

By Katie Adams

Sponsored Post

Health Care Technology And Tactics For Addressing Gaps In Patient Communication

Giving patients all the information they need to make informed decisions is crucial. However, common challenges often keep medical teams from achieving that.

By Martti

Latest Video

Latest News

Payers

State Mitigation Strategies Could Blunt Medicaid Coverage Losses

An Urban Institute report finds that the One Big Beautiful Bill Act could cause 5–10 million people to lose Medicaid coverage by 2028, with outcomes heavily dependent on how states implement work requirements and eligibility rules.

By Marissa Plescia

BioPharma, Pharma

Kailera Plans IPO for Obesity Drug That Could Top Lilly’s Zepbound

Kailera Therapeutics’ planned IPO will fund ongoing clinical development of a pipeline led by a drug that could rival Eli Lilly’s Zepbound in both efficacy and tolerability. Meanwhile, Renaissance Capital’s recap of first quarter 2026 IPOs shows slowing activity amid market turbulence from tariffs and war.

By Frank Vinluan

Sponsored Post

How Artera is Using Agentic AI to Humanize Patient Care

Artera President Tom McIntyre talks about the practical application of AI in healthcare.

By Artera and MedCity News

BioPharma

MedCity Pivot Podcast: How Fujifilm Tackled An Existential Crisis

Fujifilm went from being the no. 1 camera film company to seeing sales tumble as consumers switched to digital cameras. Lars Petersen, CEO of the company's biotechnologies business, explains how the company pivoted to becoming a partner of the life sciences industry.

By Arundhati Parmar

MedCity Influencers

AI Is Fueling a New Arms Race in Healthcare: Here’s How We Stop It

Rather than using AI to compete, we must design AI to collaborate. As the regulatory landscape evolves and industry pledges push for real-time, electronic, and transparent authorizations, the imperative is clear: technology must bridge the payer-provider divide, not widen it.

By Matt Cunningham

Sponsored Post

Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]

How to turn analytics into actual policy outcomes.

By Sellers Dorsey and MedCity News

MedCity Influencers

Red Light Therapy’s Regulatory Implications

For consumers and clinicians the difference between “FDA-cleared,” “FDA-registered,” and general wellness products is not always obvious. Clear communication about intended use and supporting evidence is essential for maintaining trust.

By Aman Kamasani

Opinion

Why CREST-2 Trial Results Should Inform, Not Replace, Clinical Judgment

While CREST-2 can stand as a guideline for understanding ACS therapies in case-by-case scenarios, it's critical that trial conclusions do not replace clinical judgment and years of previous research.

By Dr. Keith D. Calligaro, Dr. Ali F. AbuRahma and Dr. Marc L. Schermerhorn

Sponsored Post

The Mechanics of a More Connected Healthcare Ecosystem [Video]

Arbiter’s Anjali Jameson on hospital and payer alignment.

By Arbiter and MedCity News

Health Tech

Everlywell, Jona Team Up to Expand Access to Gut Microbiome Test

Through a new partnership, consumers nationwide can access Jona’s gut microbiome test on Everlywell’s platform.

By Marissa Plescia

BioPharma

FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune Disorder

Rocket Pharmaceuticals received FDA approval for Kresladi, a gene therapy developed to treat leukocyte-adhesion deficiency type 1, an inherited immunodeficiency that can become fatal to infants and young children. Kresladi is the first gene therapy for this ultra-rare disease and the first commercial product for Rocket.

By Frank Vinluan

Artificial Intelligence, Hospitals, Health Tech

Work Safety Concept - regulations and standard in medical hospital. Doctor offers safety first sign on virtual screen

How Are Health Systems Assessing ROI for AI Tools?

Michael Meucci, CEO of health data platform Arcadia, thinks health systems are changing their thinking about ROI when it comes to AI projects. As providers face tighter budgets, he said they’re broadening how they measure AI’s ROI, including benefits like reducing clinician burnout.

By Katie Adams

MedCity Influencers, Health IT

A robot hand and a doctor's hand with a medical technology icon. A concept for human and AI collaboration in healthcare, robotic-assisted surgery, and the future of medicine.

Scaling Autonomous AI in Healthcare Without Compromising Clinical Trust

AI in healthcare will not fail because the models are weak. It will stall when leaders hesitate to redesign how decisions are made, measured and governed.

By Ganesh Nathella

MedCity Influencers

Large blue dollar sign resting on a pink surface, surrounded by white arrows pointing in various directions, with a prominent red arrow directing attention toward the dollar sign healthcare opportunity

The Cost Blind Spot: Why Non-Clinical Spend Is Healthcare’s Untapped Opportunity

Providers that embrace benchmarks from outside of healthcare and move toward improved non-clinical spend management will unlock the resilience, innovation, and possibilities needed to stay strong in the years ahead.

By Matt Gattuso

Opinion

AI Can Expand Access to Healthcare — But Only With Human Action

Health systems can turn insights into action, ensuring that preventive care actually happens by combining accurate risk prediction with human outreach and careful planning.

By Carri Chan

BioPharma, Pharma

Taking a Page From Cancer Drugs, Autoimmune Biotech Alumis Aims for Precision Immunology

Alumis’s genomic research guided its development of envudeucitinib, a TYK2 inhibitor that some analysts now view as best in class. The Phase 3 results that will support a planned FDA submission in plaque psoriasis are scheduled for presentation this weekend during the American Academy of Dermatology annual meeting in Denver.

By Frank Vinluan

Health Tech, Payers

UnitedHealthcare Unveils AI Companion to Improve Navigation

UnitedHealthcare launched Avery, an AI assistant to help members manage benefits and care with live support backup.

By Marissa Plescia